Author:
Zein-El-Din Anna,Abdo Rami,Elbachti Amina,Boustani Gabriel,Salik Dany,Pourjavan Sayeh
Abstract
Abstract
Background
Hodgkin’s lymphoma (HL) is an extremely rare cause of ocular inflammation that is usually not considered in the typical workup of uveitis and other eye diseases. A few cases of ocular inflammation were reported previously showcasing HL with absence of typical symptoms of HL at presentation. Acknowledging the potential ocular inflammation associated with HL can prompt ophthalmologists to broaden their diagnostic approach and collaborate with internal medicine departments to investigate this rare yet significant etiology.
Case presentation
A 17-year-old Caucasian woman presenting unilateral panuveitis was later diagnosed with HL. The ocular findings were non-necrotizing scleritis, anterior uveitis, vitritis, white/yellowish chorioretinal lesions, papillitis and vasculitis. A left supra-clavicular lymph node biopsy confirmed the diagnosis of nodular sclerosing Hodgkin’s lymphoma stage IIB. Other causes of uveitis were excluded. Chemotherapy led to remission of the disease and the ocular lesions became quiescent with persistent pigmented chorioretinal scars.
Conclusions
Hodgkin's lymphoma should be considered in the differential diagnosis of diseases that can occasionally be revealed by unilateral ocular inflammation. A comprehensive, multidisciplinary approach is key to properly assessing such cases.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. PDQ Adult Treatment Editorial Board. Hodgkin Lymphoma Treatment (PDQ®): Patient Version. In: PDQ Cancer Information Summaries. National Cancer Institute (US); 2002. http://www.ncbi.nlm.nih.gov/books/NBK65804/. Accessed 27 Feb 2024.
2. Piris MA, Medeiros LJ, Chang KC. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Pathology (Phila). 2020;52(1):154–65. https://doi.org/10.1016/j.pathol.2019.09.005.
3. Shanbhag S, Ambinder R. Hodgkin Lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018;68(2):116–32. https://doi.org/10.3322/caac.21438.
4. Eichenauer DA, Aleman BMP, André M, et al. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv19–29. https://doi.org/10.1093/annonc/mdy080.
5. Momotow J, Borchmann S, Eichenauer DA, Engert A, Sasse S. Hodgkin lymphoma-review on pathogenesis, diagnosis, current and future treatment approaches for adult patients. J Clin Med. 2021;10(5):1125. https://doi.org/10.3390/jcm10051125.